Catalyst Wire Dossier Catalyst Wire Dossier

L19IL2/TNF

· Philogen S.p.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for L19IL2/TNF, covering 2026-03-09 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) [Phase 2]

See pricing